Literature DB >> 9368046

The tetramerization region of the retinoid X receptor is important for transcriptional activation by the receptor.

S Kersten1, P R Reczek, N Noy.   

Abstract

The retinoid X receptor (RXR), a member of the superfamily of hormone nuclear receptors, is a ligand-inducible transcription factor that is activated by the vitamin A derivative 9-cis-retinoic acid. We previously showed that RXR self-associates into tetramers with a high affinity and that ligand binding induces rapid dissociation of receptor tetramers to smaller species. Here, the RXR region that is responsible for mediating tetramer formation is identified. It is shown that this interface, which we term the "tetramerization domain," critically contains two consecutive phenylalanine residues located at the C-terminal region of the receptor. Mutation of these residues is sufficient to disrupt RXR tetramers without affecting the overall fold of the protein or interfering with ligand binding, dimer formation, or DNA binding by the receptor. Nevertheless, the tetramer-impaired mutant was found to be transcriptionally defective. The newly characterized tetramerization domain and the previously identified main dimerization interface of RXR act autonomously to affect separate intersubunit interactions that, overall, lead to formation of tetramers. Protein-protein interactions mediated by the tetramerization domain, but not those that involve the dimerization interface, are disrupted following ligand binding by RXR. Overall, these data attest to the specificity of the interaction and implicate the tetramerization interface in playing a direct role in regulating transcriptional activation by RXR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368046     DOI: 10.1074/jbc.272.47.29759

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Identification of sequence variants influencing immunoglobulin levels.

Authors:  Stefan Jonsson; Gardar Sveinbjornsson; Aitzkoa Lopez de Lapuente Portilla; Bhairavi Swaminathan; Rosina Plomp; Gillian Dekkers; Ram Ajore; Mina Ali; Arthur E H Bentlage; Evelina Elmér; Gudmundur I Eyjolfsson; Sigurjon A Gudjonsson; Urban Gullberg; Arnaldur Gylfason; Bjarni V Halldorsson; Markus Hansson; Hilma Holm; Åsa Johansson; Ellinor Johnsson; Aslaug Jonasdottir; Bjorn R Ludviksson; Asmundur Oddsson; Isleifur Olafsson; Sigurgeir Olafsson; Olof Sigurdardottir; Asgeir Sigurdsson; Lilja Stefansdottir; Gisli Masson; Patrick Sulem; Manfred Wuhrer; Anna-Karin Wihlborg; Gudmar Thorleifsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Gestur Vidarsson; Ingileif Jonsdottir; Björn Nilsson; Kari Stefansson
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

2.  Inhibition of mammary carcinoma cell growth by RXR is mediated by the receptor's oligomeric switch.

Authors:  Rubina Yasmin; Padmamalini Kannan-Thulasiraman; Hiroyuki Kagechika; Marcia I Dawson; Noa Noy
Journal:  J Mol Biol       Date:  2010-02-24       Impact factor: 5.469

Review 3.  Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites.

Authors:  Xiao-kun Zhang; Ying Su; Liqun Chen; Fan Chen; Jie Liu; Hu Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-12-01       Impact factor: 6.150

4.  Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix.

Authors:  R T Gampe; V G Montana; M H Lambert; G B Wisely; M V Milburn; H E Xu
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

5.  Danthron functions as a retinoic X receptor antagonist by stabilizing tetramers of the receptor.

Authors:  Haitao Zhang; Rong Zhou; Li Li; Jing Chen; Lili Chen; Chenjing Li; Hong Ding; Liang Yu; Lihong Hu; Hualiang Jiang; Xu Shen
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

6.  β-Apo-13-carotenone regulates retinoid X receptor transcriptional activity through tetramerization of the receptor.

Authors:  Jian Sun; Sureshbabu Narayanasamy; Robert W Curley; Earl H Harrison
Journal:  J Biol Chem       Date:  2014-10-16       Impact factor: 5.157

Review 7.  Targeting truncated RXRα for cancer therapy.

Authors:  Xiaokun Zhang; Hu Zhou; Ying Su
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-21       Impact factor: 3.848

Review 8.  Retinoic acid actions through mammalian nuclear receptors.

Authors:  Pengxiang Huang; Vikas Chandra; Fraydoon Rastinejad
Journal:  Chem Rev       Date:  2013-12-05       Impact factor: 60.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.